logo dark logoo light logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
logo dark logoo light logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
mobile logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
July 22, 2021
Uncategorized

全美新冠染疫病歿人數突破60萬 死亡率大減

根據路透統計,全美新冠肺炎14日病歿人數突破60萬人的里程碑,約占全球近400萬病歿人數15%;而在全美疫情緩和之際,許多接種率低的州又見疫情升溫。

疫苗有效減緩染疫病沒速度;全美新冠病歿人數從40萬人增至50萬人僅花35天,但再增至60萬人則花了113天,這也是全美自疫情之初以來,以第二慢的速度新增10萬病歿人數。

出訪比利時的拜登總統14日表示有太多人染疫喪命,「我們還要更努力打敗病毒,現在還不能鬆懈。」

統計顯示,全美過去一周平均單日病歿人數已從1月高峰下降近九成,5月新冠病歿人數為1萬8578人,也比1月大減81%。全美疫情趨緩,但八州新增確診卻見成長,而且其中七州接種率低於全國平均;在阿拉巴馬、阿肯色、夏威夷、密蘇里、內華達、猶他、懷俄明與德州,過去一周平均新增確診人數高於過去兩周單日平均。

根據聯邦疾病防治中心(CDC)14日數據,全美已有52.5%總人口接種至少一劑疫苗;43.7%總人口已完成接種。4月中以來的接種率大幅下降,上周單日平均下降至約110萬劑,比接種高峰時期減少67%。

分享:

SHARE THIS ARTICLE

by admin
0
0
Previous post 紐約州議會通過法案 為庫默彈劾調查撥款
Next post 華盛頓廣場公園宵禁引關注 今舉行公開會議

即時新聞

賓州警方執行搜捕令時遭槍擊 致三死兩傷

September 18, 2025

賓州警方執行搜捕令時遭槍擊 致三死兩傷

September 18, 2025

川普與英相施凱爾簽署科技協議 加強美英合作

September 18, 2025

擬重新設計堅尼路 紐約市交通局徵詢公眾意見

September 18, 2025

聯大會議和猶太新年將至 紐約市警公佈安全計劃

September 18, 2025
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Advertisement

Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

Others

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

SAVE & ACCEPT

Terms and Conditions - Privacy Policy